Butt Tausif 4
4 · ChemoCentryx, Inc. · Filed Feb 24, 2022
Insider Transaction Report
Form 4
Butt Tausif
EVP, Chief Operating Officer
Transactions
- Award
Restricted Stock Units
2022-02-22+41,400→ 41,400 total→ Common Stock (41,400 underlying) - Award
Stock Option (right to buy)
2022-02-22+52,200→ 52,200 totalExercise: $29.83Exp: 2032-02-22→ Common Stock (52,200 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of CCXI common stock.
- [F2]The restricted stock units awarded on February 22, 2022, vests in four equal installments on January 1, 2023, January 1, 2024, January 1, 2025, and January 1, 2026, subject to the Reporting Person's continued service to the Company on such date. Shares will be delivered to the Reporting Person within thirty (30) days following vest date.
- [F3]The option was granted on February 22, 2022, and 25% of the total number of shares of common stock subject to the option vests on January 1, 2023, and 1/48th of the total number of shares of common stock subject to the option vests monthly thereafter, subject to the Reporting Person's continued service to the Company on each such vesting date.
- [F4]Not applicable.